CARTER BANKSHARES INCCARE
ASignal's systematic analysis rates CARE as Neutral.
Reflects the latest available analysis · analyzed Sep 27, 2026
The case on CARE
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong revenue growth (68.3% YoY)
- Exceptional earnings growth (253.9% YoY)
- High return on equity (27.22%)
- Low P/E ratio (5.23x) indicating potential undervaluation
- High net profit margin (44.92%)
- Significant operating cash flow ($67.26M)
- Bearish MACD signal (MACD < signal line)
- Negative price momentum
- Price below 20-day and 50-day moving averages
- No Reddit mentions indicating low retail interest
- High dividend yield (132%) potentially unsustainable
- Gross margin reported as 0.00%, conflicting with high net margins
See the full verdict on CARE
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes CARE
Most investors never get a second opinion, let alone several. ASignal runs CARE past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.